← Eichor
Study identifier: NCT06647498 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Condition: Alzheimers Disease · Dementia · Alzheimers Disease, Familial  ·  Sponsor: Washington University School of Medicine

PhasePhase 2/Phase 3
Planned participants280
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The purpose of this research study is to test the study drug, referred to as remternetug, to determine its effectiveness for the study treatment of asymptomatic (at risk) Alzheimer disease in individuals with AD-causing mutations. This study will also investigate the effects of remternetug on biomarkers (measures of the disease including brain scans, blood and spinal fluid tests), examine safety data to identify any potential benefits or risks, and examine how well participants can tolerate remternetug. Stage 1 will determine if treatment with the study drug prevents or reverses amyloid beta (Aβ) accumulation compared with placebo in participants with dominantly inherited Alzheimer's disease (DIAD). Stage 2 will evaluate the effect of early anti-amyloid treatment on downstream biomarkers of AD in treated participants compared to external control groups.

This description comes directly from the study's public registry record.

Talk to the study team

Jamie Bartzel  ·  844-DIANEXR (342-6397)  ·  dianexr@wustl.edu

Ellen Ziegemeier  ·  844-DIANEXR (342-6397)  ·  dianexr@wustl.edu

Always discuss trial participation with your own doctor first.

Locations (37)

University of Alabama in BirminghamBirmingham, Alabama, United StatesRecruiting
University of California San Diego Medical CenterLa Jolla, California, United StatesRecruiting
University of Southern CalifonriaLos Angeles, California, United StatesNot Yet Recruiting
Yale University School of MedicineNew Haven, Connecticut, United StatesRecruiting
Emory UniversityAtlanta, Georgia, United StatesRecruiting
Advocate Lutheran General HospitalPark Ridge, Illinois, United StatesRecruiting
Indiana University School of MedicineIndianapolis, Indiana, United StatesRecruiting
Washington University in St. LouisSt Louis, Missouri, United StatesRecruiting
New York University Medical CenterNew York, New York, United StatesRecruiting
University of PittsburghPittsburgh, Pennsylvania, United StatesRecruiting
Butler HospitalProvidence, Rhode Island, United StatesRecruiting
Kerwin Research and Memory CenterDallas, Texas, United StatesRecruiting

+ 25 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06647498